Literature DB >> 24888687

Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.

Pi-Ling Chang1, Yu-Hua Hsieh2, Chao-Cheng Wang3, M Margaret Juliana4, Yuko Tsuruta3, Laura Timares3, Craig Elmets5, Kang-Jey Ho6.   

Abstract

BACKGROUND: Osteopontin (OPN) is a matricellular glycoprotein that is markedly expressed in cutaneous squamous cell carcinomas (cSCCs) and in actinic keratoses implicating its role in photocarcinogenesis.
OBJECTIVE: To determine whether OPN facilitates the development of cSCC and its function.
METHODS: cSCCs development was compared between wild-type (WT) and OPN-null mice subjected to UVB irradiation for 43 weeks. UVB-induced OPN expression was determined by Western blot, immunoprecipitation, ELISA, and semi-quantitative RT-PCR. Epidermal layer and TUNEL analyses assessed if OPN mediates UVB-induced epidermal hyperplasia or suppresses UVB-induced apoptosis of basal keratinocytes, respectively. In vitro experiments determined whether OPN enhances cell survival of UVB-induced apoptosis and its potential mechanisms. Immunohistochemical analyses of epidermis assessed the expression of CD44 and focal adhesion kinase (FAK), molecules that mediate OPN survival function.
RESULTS: Compared to female WT mice, OPN-null mice did not develop cSCCs. UVB irradiation stimulated OPN protein expression in the dorsal skin by 11h and remains high at 24-48h. OPN did not mediate UVB-induced epidermal hyperplasia; instead, it protected basal keratinocytes from undergoing apoptosis upon UVB exposure. Likewise, the addition of OPN suppressed UVB-induced OPN-null cSCC cell apoptosis, the activation of caspase-9 activity, and increased phosphorylation of FAK at Y397. Furthermore, the expression of CD44 and FAK in WT mice epidermis was greater than that of OPN-null mice prior to and during early acute UVB exposure.
CONCLUSION: These data support the hypothesis that chronic UVB-induced OPN expression protects the survival of initiated basal keratinocytes and, consequently, facilitates cSCC develop.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24888687      PMCID: PMC4128184          DOI: 10.1016/j.jdermsci.2014.05.002

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  73 in total

1.  Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.

Authors:  Li Yang; Ling Wei; Wei Zhao; Xingwu Wang; Gang Zheng; Meizhu Zheng; Xianrang Song; Wenshu Zuo
Journal:  Mol Med Rep       Date:  2011-11-21       Impact factor: 2.952

2.  Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.

Authors:  Hanna Siiskonen; Kari Törrönen; Timo Kumlin; Kirsi Rilla; Markku I Tammi; Raija H Tammi
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

Review 3.  The role of integrins in tumorigenesis and metastasis.

Authors:  R J Sanders; F Mainiero; F G Giancotti
Journal:  Cancer Invest       Date:  1998       Impact factor: 2.176

4.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

5.  Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation.

Authors:  T M Oberyszyn; K L Tober; M S Ross; F M Robertson
Journal:  Mol Carcinog       Date:  1998-05       Impact factor: 4.784

6.  Host-derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells.

Authors:  Yu-Hua Hsieh; M Margaret Juliana; Kang-Jey Ho; Hui-Chien Kuo; Henri van der Heyde; Craig Elmets; Pi-Ling Chang
Journal:  Int J Cancer       Date:  2011-10-20       Impact factor: 7.396

7.  Expression of bone matrix proteins, osteonectin and osteopontin, in salivary pleomorphic adenomas.

Authors:  K Kusafuka; A Yamaguchi; T Kayano; T Takemura
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

8.  Establishment and characterization of an osteopontin-null cutaneous squamous cell carcinoma cell line.

Authors:  Yu-Hua Hsieh; M Margaret Juliana; Pi-Ling Chang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02       Impact factor: 2.416

9.  Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an Arg-Gly-Asp-dependent-focal adhesion kinase-caspase-8 axis.

Authors:  Yu-Hua Hsieh; Henri van der Heyde; Eok-Soo Oh; Jun-Lin Guan; Pi-Ling Chang
Journal:  Mol Carcinog       Date:  2013-11-19       Impact factor: 4.784

10.  NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival.

Authors:  M Scatena; M Almeida; M L Chaisson; N Fausto; R F Nicosia; C M Giachelli
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

View more
  4 in total

1.  The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.

Authors:  Chu-Fang Chou; Yu-Hua Hsieh; Clinton J Grubbs; Venkatram R Atigadda; James A Mobley; Reinhard Dummer; Donald D Muccio; Isao Eto; Craig A Elmets; W Timothy Garvey; Pi-Ling Chang
Journal:  J Dermatol Sci       Date:  2018-03-15       Impact factor: 4.563

2.  Nerve Growth Factor (NGF) as Partaker in the Modulation of UV-Response in Cultured Human Conjunctival Fibroblasts.

Authors:  Graziana Esposito; Bijorn Omar Balzamino; Maria Luisa Rocco; Luigi Aloe; Alessandra Micera
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

3.  Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis.

Authors:  Frank Peinemann; Marco Harari; Sandra Peternel; Thalia Chan; David Chan; Alexander M Labeit; Thilo Gambichler
Journal:  Cochrane Database Syst Rev       Date:  2020-05-05

4.  Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis.

Authors:  Jingwei Liu; Caiyun He; Quan Yuan; Zhenning Wang; Chengzhong Xing; Yuan Yuan
Journal:  Onco Targets Ther       Date:  2015-12-30       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.